Keeping you up to date on recent developments in orthopedics, including: Lab engineers 3D-functional bone tissues; Comparison of early postoperative pain after first vs. second total knee arthroplasty; Vitamin B3 revitalizes energy metabolism in muscle disease; Worldwide IOF-ISCD survey of bone densitometry units published.
Keeping you up to date on recent developments in oncology, including: New LAT1 inhibitor may improve outcomes in cancer as part of combo therapy; Subdividing and conquering PDAC; Cell competition links hyperinsulinemia to cancer; Protons show well in study against alternatives.
Keeping you up to date on recent developments in cardiology, including: Robotic PCI reduces radiation exposure; COVID-19 and cardiovascular problems; Heart attack prevention falls short for stroke, PAD patients; Integrated herpesvirus-6 is pre-eclampsia risk factor.
Keeping you up to date on recent developments in neurology, including: Study finds tDCS does not affect metabolism; AI successfully used to identify different types of brain injuries; Dynamic stimulation of the visual cortex allows blind and sighted people to 'see' shapes.
BioWorld looks at translational medicine, including: Acid test for therapeutic peptides; Designer proteins for RSV vaccine; Subdividing and conquering PDAC; The world according to GARP; Cell competition links hyperinsulinemia to cancer.
Keeping you up to date on recent developments in diagnostics, including: Accelerating de novo human genome assembly; DL model increases detection of pulmonary embolism; Carbohydrate metabolism implicated in neuropathy; T-cell mutations contribute to GVHD.
Keeping you up to date on recent developments in orthopedics, including: UCLA scientists create first roadmap of human skeletal muscle development; Excess coffee consumption a culprit for poor health; Arthritis clinical trial shows support for dextrose injection to alleviate knee pain; Gene therapy in mice builds muscle, reduces fat.
Keeping you up to date on recent developments in oncology, including: New nanoparticle proposed as treatment for a ‘wide range of cancers’; CD163-expressing macrophages a sign of poor outcomes; Mevion inks deal for protons in Texas; PSMA PET-CT show well in study of prostate cancer metastasis.